Invivyd logo

Invivyd

BrandNew Haven, ConnecticutWebsite

Company Overview

Invivyd, Inc. (Nasdaq: IVVD) creates medicines that are more potent and resistant to virus evolution than the human immune system. We deploy a proprietary integrated technology platform unique in the industry to assess, monitor, drug and adapt to create best in class antibodies.In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.#covid19 #immunocompromised
Founded
2020
Headquarters
New Haven, Connecticut
Employees
51-200
5.9% growth last 12mo
Marketing Team
10
8% of company

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Salaries

Community Salary Data

Help build salary transparency at Invivyd. Share your compensation anonymously.

Contribute

Reviews

Jobs